The Food and Drug Administration (FDA) announces its intention to accept and consider a single source application for award of a Cooperative Agreement to the World Health Organization (WHO) in support of collaboration in regulatory systems strengthening, development of norms and standards, and innovative
credit:
research to advance global access to safe and effective biological products that meet international standards.